US 8916580
Spiro-oxindole compounds and their use as therapeutic agents
granted A61PA61P1/00A61P1/02
Quick answer
US patent 8916580 (Spiro-oxindole compounds and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00